Femasys ceo and founder kathy lee-sepsick meets with members of congress to raise awareness of the company and discuss women's healthcare initiatives

Atlanta, april 18, 2024 (globe newswire) -- femasys inc. (nasdaq: femy), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, today announces its ceo and founder kathy lee-sepsick has met with several members of congress to discuss the current women's healthcare landscape. further, lee-sepsick is raising awareness of femasys and the status of its reproductive products in light of the recently announced women's health initiative from the white house. in mid-march president biden released an executive order, which calls for a $200m investment in research for women's health and a coordinated approach from more than 20 federal government agencies in addition to the $100m investment announced in november 2023.
FEMY Ratings Summary
FEMY Quant Ranking